Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter April 14, 2015

Porous silicon for cancer therapy: from fundamental research to the clinic

  • Adi Tzur-Balter

    Adi Tzur-Balter earned her BSc in Biotechnology Engineering in 2007 from the Ben-Gurion University of the Negev, Israel. In 2008, she joined the group of Professor Ester Segal at the Department of Biotechnology and Food Engineering at the Technion – Israel Institute of Technology and received her PhD degree very recently. Her PhD thesis focused on the development of nano-structured porous silicon scaffolds for controlled delivery of antineoplastic drugs. Adi is currently a research scientist at ViAqua Therapeutics Ltd, focusing on the development of tailored therapeutics for aquaculture.

    , Giorgi Shtenberg

    Giorgi Shtenberg is currently completing his doctoral studies under the auspices of the Interdepartmental Program of Biotechnology Engineering at the Technion – Israel Institute of Technology. He received his BSc in Biotechnology and Food Engineering from the Technion in 2009 and later joined the group of Professor Segal as a PhD student. His PhD research focuses on the development of optical biosensors for monitoring proteins activity. His research interests include surface chemistry, nano-engineering, microfluidics, and biological interfaces.

    and Ester Segal

    Ester Segal is an Associate Professor in the Faculty of Biotechnology and Food Engineering at the Technion – Israel Institute of Technology. She earned her BSc (cum laude) in Chemical Engineering in 1997 and her PhD in Chemical Engineering in 2004, both from the Technion. Since 2007 she has been heading the Laboratory of Multifunctional Nanomaterials. The research in her group is focused on the synthesis and characterization of nanostructured materials and their interface with soft matter, e.g., hydrogels, biomolecules, and living cells. Understanding these interfaces is circumvented for rational design of biosensors for diagnostics and new drug delivery schemes. She has authored 50 scientific publications in peer reviewed journals and has one issued and several pending US patents.

    EMAIL logo

Abstract

Porous silicon (PSi) has emerged over the past decade as a promising biomaterial for nanomedicine in general and cancer nanomedicine in particular. PSi offers a unique combination of properties, including large surface area and porous volume, biocompatibility, degradability in vivo into non-toxic silicic acid species, as well as its wealth of intrinsic optical properties (e.g., luminescence, photonic). This arsenal of properties together with the ability to tailor the PSi nanostructure and surface characteristics have led to an immense research effort directed at the development of PSi-based platforms for biomedical applications. After a brief introduction of the biology of cancer and currently practiced therapies, we provide an updated review of the progress of PSi-based platforms for cancer therapy and imaging.


Corresponding author: Ester Segal, Technion – Israel Institute of Technology, Department of Biotechnology and Food Engineering, Haifa 32000, Israel; and The Russell Berrie Nanotechnology Institute, Technion – Israel Institute of Technology, Haifa 32000, Israel, e-mail:

About the authors

Adi Tzur-Balter

Adi Tzur-Balter earned her BSc in Biotechnology Engineering in 2007 from the Ben-Gurion University of the Negev, Israel. In 2008, she joined the group of Professor Ester Segal at the Department of Biotechnology and Food Engineering at the Technion – Israel Institute of Technology and received her PhD degree very recently. Her PhD thesis focused on the development of nano-structured porous silicon scaffolds for controlled delivery of antineoplastic drugs. Adi is currently a research scientist at ViAqua Therapeutics Ltd, focusing on the development of tailored therapeutics for aquaculture.

Giorgi Shtenberg

Giorgi Shtenberg is currently completing his doctoral studies under the auspices of the Interdepartmental Program of Biotechnology Engineering at the Technion – Israel Institute of Technology. He received his BSc in Biotechnology and Food Engineering from the Technion in 2009 and later joined the group of Professor Segal as a PhD student. His PhD research focuses on the development of optical biosensors for monitoring proteins activity. His research interests include surface chemistry, nano-engineering, microfluidics, and biological interfaces.

Ester Segal

Ester Segal is an Associate Professor in the Faculty of Biotechnology and Food Engineering at the Technion – Israel Institute of Technology. She earned her BSc (cum laude) in Chemical Engineering in 1997 and her PhD in Chemical Engineering in 2004, both from the Technion. Since 2007 she has been heading the Laboratory of Multifunctional Nanomaterials. The research in her group is focused on the synthesis and characterization of nanostructured materials and their interface with soft matter, e.g., hydrogels, biomolecules, and living cells. Understanding these interfaces is circumvented for rational design of biosensors for diagnostics and new drug delivery schemes. She has authored 50 scientific publications in peer reviewed journals and has one issued and several pending US patents.

Acknowledgments

This work is partially supported by the Russell Berrie Nanotechnology Institute (RBNI) and the Lorry I. Lokey Interdisciplinary Center for Life Sciences and Engineering (LS&E). ATB gratefully acknowledges the RBNI Scholarship for Outstanding Graduate Students.

References

Ananta JS, Godin B, Sethi R, Moriggi L, Liu XW, Serda RE, Krishnamurthy R, Muthupillai R, Bolskar RD, Helm L, Ferrari M, Wilson LJ, Decuzzi P. Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast. Nat Nanotechnol 2010; 5: 815–821.10.1038/nnano.2010.203Search in Google Scholar PubMed PubMed Central

Anglin EJ, Schwartz MP, Ng VP, Perelman LA, Sailor MJ. Engineering the chemistry and nanostructure of porous silicon Fabry-Perot films for loading and release of a steroid. Langmuir 2004; 20: 11264–11269.10.1021/la048105tSearch in Google Scholar PubMed

Anglin EJ, Cheng LY, Freeman WR, Sailor MJ. Porous silicon in drug delivery devices and materials. Adv Drug Deliv Rev 2008; 60: 1266–1277.10.1016/j.addr.2008.03.017Search in Google Scholar PubMed PubMed Central

Baldo BA, Pham NH. Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch. Cancer Metastasis Rev 2013; 32: 723–761.10.1007/s10555-013-9447-3Search in Google Scholar PubMed PubMed Central

Bayliss SC, Harris PJ, Buckberry LD, Rousseau C. Phosphate and cell growth on nanostructured semiconductors. J Mater Sci Lett 1997; 16: 737–740.10.1023/A:1018581014416Search in Google Scholar

Bertrand N, Wu J, Xu X, Kamaly N, Farokhzad OC. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev 2014; 66: 2–25.10.1016/j.addr.2013.11.009Search in Google Scholar PubMed PubMed Central

Bimbo LM, Sarparanta M, Santos HA, Airaksinen AJ, Makila E, Laaksonen T, Peltonen L, Lehto VP, Hirvonen J, Salonen J. Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats. ACS Nano 2010; 4: 3023–3032.10.1021/nn901657wSearch in Google Scholar PubMed

Bimbo LM, Mäkiläb E, Laaksonen T, Lehto V-P, Salonen J, Hirvonen J, Santos HA. Drug permeation across intestinal epithelial cells using porous silicon nanoparticles. Biomaterials 2011; 32: 2625–2633.10.1016/j.biomaterials.2010.12.011Search in Google Scholar PubMed

Bonanno LM, Segal E. Nanostructured porous silicon-polymer-based hybrids: from biosensing to drug delivery. Nanomedicine 2011; 6: 1755–1770.10.2217/nnm.11.153Search in Google Scholar PubMed

Boucher Y, Baxter LT, Jain RK. Interstitial pressure-gradients in tissue-isolated and subcutaneous tumors – implications for therapy. Cancer Res 1990; 50: 4478–4484.Search in Google Scholar

Bracci L, Schiavoni G, Sistigu A, Belardelli F. Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer. Cell Death Differ 2014; 21: 15–25.10.1038/cdd.2013.67Search in Google Scholar PubMed PubMed Central

Canham LT. Bioactive silicon structure fabrication through nanoetching techniques. Adv Mater 1995; 7: 1033–1037.10.1002/adma.19950071215Search in Google Scholar

Canham L, editor. Properties of porous silicon. London: INSPEC, 1997.Search in Google Scholar

Canham LT. Nanoscale semiconducting silicon as a nutritional food additive. Nanotechnology 2007; 18: 6.10.1088/0957-4484/18/18/185704Search in Google Scholar

Canham L. Nanosilicon for nanomedicine: a step towards biodegradable electronic implants? Nanomedicine 2013; 8: 1573–1576.10.2217/nnm.13.134Search in Google Scholar

Canham L, editor. Handbook of porous silicon. Switzerland: Springer, 2014.10.1007/978-3-319-05744-6_16Search in Google Scholar

Canham LT, Newey JP, Reeves CL, Houlton MR, Loni A, Simons AJ, Cox TI. The effects of dc electric currents on the in-vitro calcification of bioactive silicon wafers. Adv Mater 1996a; 8: 847.10.1002/adma.19960081019Search in Google Scholar

Canham LT, Reeves CL, King DO, Branfield PJ, Crabb JG, Ward MCL. Bioactive polycrystalline silicon. Adv Mater 1996b; 8: 850–852.10.1002/adma.19960081020Search in Google Scholar

Canham LT, Reeves CL, Loni A, Houlton MR, Newey JP, Simons AJ, Cox TI. Calcium phosphate nucleation on porous silicon: factors influencing kinetics in acellular simulated body fluids. Thin Solid Films 1997; 297: 304–307.10.1016/S0040-6090(96)09534-XSearch in Google Scholar

Cheng L, Anglin E, Cunin F, Kim D, Sailor MJ, Falkenstein I, Tammewar A, Freeman WR. Intravitreal properties of porous silicon photonic crystals: a potential self-reporting intraocular drug-delivery vehicle. Br J Ophthalmol 2008; 92: 705–711.10.1136/bjo.2007.133587Search in Google Scholar PubMed PubMed Central

Chiappini C, Tasciotti E, Fakhoury JR, Fine D, Pullan L, Wang Y-C, Fu L, Liu X, Ferrari M. Tailored porous silicon microparticles: fabrication and properties. ChemPhysChem 2010; 11: 1029–1035.10.1002/cphc.200900914Search in Google Scholar PubMed PubMed Central

Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Ipe BI, Bawendi MG, Frangioni JV. Renal clearance of quantum dots. Nat Biotechnol 2007; 25: 1165–1170.10.1038/nbt1340Search in Google Scholar PubMed PubMed Central

Coffer JL, Whitehead MA, Nagesha DK, Mukherjee P, Akkaraju G, Totolici M, Saffie RS, Canham LT. Porous silicon-based scaffolds for tissue engineering and other biomedical applications. Phys Status Solidi A 2005; 202: 1451–1455.10.1002/pssa.200461134Search in Google Scholar

Collins I, Weber A, Levens D. Transcriptional consequences of topoisomerase inhibition. Mol Cell Biol 2001; 21: 8437–8451.10.1128/MCB.21.24.8437-8451.2001Search in Google Scholar

Cunin F, Schmedake TA, Link JR, Li YY, Koh J, Bhatia SN, Sailor MJ. Biomolecular screening with encoded porous-silicon photonic crystals. Nat Mater 2002; 1: 39–41.10.1038/nmat702Search in Google Scholar

Davis ME, Chen Z, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 2008; 7: 771–782.10.1038/nrd2614Search in Google Scholar

Decuzzi P, Godin B, Tanaka T, Lee SY, Chiappini C, Liu X, Ferrari M. Size and shape effects in the biodistribution of intravascularly injected particles. J Control Release 2010; 141: 320–327.10.1016/j.jconrel.2009.10.014Search in Google Scholar

Doherty GJ, McMahon HT. Mechanisms of endocytosis. Annual review of biochemistry. Palo Alto: Annual Reviews, 2009.10.1146/annurev.biochem.78.081307.110540Search in Google Scholar

Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Globocan 2012: Cancer incidence and mortality worldwide. International Agency for Research on Cancer, 2012 (cited 27 December 2014).Search in Google Scholar

Ferrari M. Experimental therapies vectoring siRNA therapeutics into the clinic. Nat Rev Clin Oncol 2010; 7: 485–486.10.1038/nrclinonc.2010.131Search in Google Scholar

Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 2007; 8: 226–234.10.1016/S1470-2045(07)70039-6Search in Google Scholar

Gizzatov A, Stigliano C, Ananta JS, Sethi R, Xu R, Guven A, Ramirez M, Shen H, Sood A, Ferrari M, Wilson LJ, Liu X, Decuzzi P. Geometrical confinement of Gd(DOTA) molecules within mesoporous silicon nanoconstructs for MR imaging of cancer. Cancer Lett 2014; 352: 97–101.10.1016/j.canlet.2014.06.001Search in Google Scholar PubMed PubMed Central

Glatstein E, Glick J, Kaiser L, Hahn SM. Should randomized clinical trials be required for proton radiotherapy? An alternative view. J Clin Oncol 2008; 26: 2438–2439.10.1200/JCO.2008.17.1843Search in Google Scholar PubMed

Godin B, Gu JH, Serda RE, Bhavane R, Tasciotti E, Chiappini C, Liu XW, Tanaka T, Decuzzi P, Ferrari M. Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation. J Biomed Mater Res Part A 2010; 94A: 1236–1243.10.1002/jbm.a.32807Search in Google Scholar PubMed PubMed Central

Godin B, Tasciotti E, Liu X, Serda RE, Ferrari M. Multistage nanovectors: from concept to novel imaging contrast agents and therapeutics. Acc Chem Res 2011; 44: 979–989.10.1021/ar200077pSearch in Google Scholar PubMed PubMed Central

Godin B, Chiappini C, Srinivasan S, Alexander JF, Yokoi K, Ferrari M, Decuzzi P, Liu XW. Discoidal porous silicon particles: fabrication and biodistribution in breast cancer bearing mice. Adv Funct Mater 2012; 22: 4225–4235.10.1002/adfm.201200869Search in Google Scholar PubMed PubMed Central

Goh AS-W, Chung AY-F, Lo RH-G, Lau T-N, Yu SW-K, Chng M, Satchithanantham S, Loong SL-E, Ng DC-E, Lim B-C, Connor S, Chow PK-H. A novel approach to brachytherapy in hepatocellular carcinoma using a phosphorous32 (32P) brachytherapy delivery device – a first-in-man study. Int J Radiat Oncol Biol Phys 2007; 67: 786–792.10.1016/j.ijrobp.2006.09.011Search in Google Scholar PubMed

Gorustovich AA, Monserrat AJ, Guglielmotti MB, Cabrini RL. Effects of intraosseous implantation of silica-based bioactive glass particles on rat kidney under experimental renal failure. J Biomater Appl 2007; 21: 431–442.10.1177/0885328206068061Search in Google Scholar PubMed

Gu L, Park JH, Duong KH, Ruoslahti E, Sailor MJ. Magnetic luminescent porous silicon microparticles for localized delivery of molecular drug payloads. Small 2010; 6: 2546–2552.10.1002/smll.201000841Search in Google Scholar PubMed PubMed Central

Gu L, Ruff LE, Qin Z, Corr M, Hedrick SM, Sailor MJ. Nanoparticles for immunotherapy: multivalent porous silicon nanoparticles enhance the immune activation potency of agonistic CD40 antibody (Adv. Mater. 29/2012). Adv Mater 2012; 24: 4025–4025.10.1002/adma.201290177Search in Google Scholar

Gu L, Hall DJ, Qin ZT, Anglin E, Joo J, Mooney DJ, Howell SB, Sailor MJ. In vivo time-gated fluorescence imaging with biodegradable luminescent porous silicon nanoparticles. Nat Commun 2013; 4: 7.10.1038/ncomms3326Search in Google Scholar PubMed PubMed Central

Harris AL. Hypoxia – a key regulatory factor in tumour growth. Nat Rev Cancer 2002; 2: 38–47.10.1038/nrc704Search in Google Scholar PubMed

Helmlinger G, Yuan F, Dellian M, Jain RK. Interstitial pH and pO(2) gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med 1997; 3: 177–182.10.1038/nm0297-177Search in Google Scholar PubMed

Hildebrandt B, Wust P, Ahlers O, Dieing A, Sreenivasa G, Kerner T, Felix R, Riess H. The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol 2002; 43: 33–56.10.1016/S1040-8428(01)00179-2Search in Google Scholar

Hong C, Lee J, Son M, Hong SS, Lee C. In-vivo cancer cell destruction using porous silicon nanoparticles. Anti-Cancer Drugs 2011a; 22: 971–977.10.1097/CAD.0b013e32834b859cSearch in Google Scholar PubMed

Hong C, Lee J, Zheng H, Hong S-S, Lee C. Porous silicon nanoparticles for cancer photothermotherapy. Nanoscale Res Lett 2011b; 6: 321–328.10.1186/1556-276X-6-321Search in Google Scholar PubMed PubMed Central

Hua MY, Yang HW, Chuang CK, Tsai RY, Chen WJ, Chuang KL, Chang YH, Chuang HC, Pang ST. Magnetic-nanoparticle-modified paclitaxel for targeted therapy for prostate cancer. Biomaterials 2010; 31: 7355–7363.10.1016/j.biomaterials.2010.05.061Search in Google Scholar PubMed

Iversen TG, Skotland T, Sandvig K. Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies. Nano Today 2011; 6: 176–185.10.1016/j.nantod.2011.02.003Search in Google Scholar

Jain RK. Determinants of tumor blood-flow – a review. Cancer Res 1988; 48: 2641–2658.Search in Google Scholar

Jain RK, Tong RT, Munn LL. Effect of vascular normalization, by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model. Cancer Res 2007; 67: 2729–2735.10.1158/0008-5472.CAN-06-4102Search in Google Scholar PubMed PubMed Central

Jane A, Dronov R, Hodges A, Voelcker NH. Porous silicon biosensors on the advance. Trends Biotechnol 2009; 27: 230–239.10.1016/j.tibtech.2008.12.004Search in Google Scholar PubMed

Juarranz A, Jaen P, Sanz-Rodriguez F, Cuevas J, Gonzalez S. Photodynamic therapy of cancer. Basic principles and applications. Clin Transl Oncol 2008; 10: 148–154.10.1007/s12094-008-0172-2Search in Google Scholar PubMed

Kallinen AM, Sarparanta MP, Liu D, Makila EM, Salonen JJ, Hirvonen JT, Santos HA, Airaksinen AJ. In vivo evaluation of porous silicon and porous silicon solid lipid nanocomposites for passive targeting and imaging. Mol Pharmaceutics 2014; 11: 2876–2886.10.1021/mp500225bSearch in Google Scholar PubMed

Kam NWS, O’Connell M, Wisdom JA, Dai HJ. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc Natl Acad Sci USA 2005; 102: 11600–11605.10.1073/pnas.0502680102Search in Google Scholar PubMed PubMed Central

Kilian KA, Boecking T, Gooding JJ. The importance of surface chemistry in mesoporous materials: lessons from porous silicon biosensors. Chem Commun 2009; 6: 630–640.10.1039/B815449JSearch in Google Scholar

Kinnari PJ, Hyvonen MLK, Makila EM, Kaasalainen MH, Rivinoja A, Salonen JJ, Hirvonen JT, Laakkonen PM, Santos HA. Tumour homing peptide-functionalized porous silicon nanovectors for cancer therapy. Biomaterials 2013; 34: 9134–9141.10.1016/j.biomaterials.2013.08.034Search in Google Scholar PubMed

Kinsella JM, Ananda S, Andrew JS, Grondek JF, Chien MP, Scadeng M, Gianneschi NC, Ruoslahti E, Sailor MJ. Enhanced magnetic resonance contrast of Fe3O4 nanoparticles trapped in a porous silicon nanoparticle host. Adv Mater 2011; 23: 248.10.1002/adma.201101877Search in Google Scholar PubMed PubMed Central

Koukourakis G, Kelekis N, Armonis V, Kouloulias V. Brachytherapy for prostate cancer: a systematic review. Adv Urol 2009; 2009: 327945.10.1155/2009/327945Search in Google Scholar PubMed PubMed Central

Kovalainen M, Monkare J, Kaasalainen M, Riikonen J, Lehto VP, Salonen J, Herzig KH, Jarvinen K. Development of porous silicon nanocarriers for parenteral peptide delivery. Mol Pharm 2013; 10: 353–359.10.1021/mp300494pSearch in Google Scholar PubMed

Kumar R, Kaur M, Silakari O. Physiological modulation approaches to improve cancer chemotherapy: a review. Anti-Cancer Agents Med Chem 2014; 14: 713–749.10.2174/18715206113136660364Search in Google Scholar PubMed

Lee C, Kim H, Cho YJ, Lee WI. The properties of porous silicon as a therapeutic agent via the new photodynamic therapy. J Mater Chem 2007; 17: 2648–2653.10.1039/b700892aSearch in Google Scholar

Lee C, Kim H, Hong C, Kim M, Hong SS, Lee DH, Lee WI. Porous silicon as an agent for cancer thermotherapy based on near-infrared light irradiation. J Mater Chem 2008; 18: 4790–4795.10.1039/b808500eSearch in Google Scholar

Lee C, Hong C, Kim H, Kang J, Zheng HM. TiO2 nanotubes as a therapeutic agent for cancer thermotherapy. Photochem Photobiol 2010; 86: 981–989.10.1111/j.1751-1097.2010.00731.xSearch in Google Scholar PubMed

Levin WP, Kooy H, Loeffler JS, DeLaney TF. Proton beam therapy. Br J Cancer 2005; 93: 849–854.10.1038/sj.bjc.6602754Search in Google Scholar PubMed PubMed Central

Li X, John JS, Coffer JL, Chen Y, Pinizzotto RF, Newey J, Reeves C, Canham LT. Porosified silicon wafer structures impregnated with platinum anti-tumor compounds: fabrication, characterization, and diffusion studies. Biomed Microdevices 2000; 2: 265–272.10.1023/A:1009951121205Search in Google Scholar

Li YY, Cunin F, Link JR, Gao T, Betts RE, Reiver SH, Chin V, Bhatia SN, Sailor MJ. Polymer replicas of photonic porous silicon for sensing and drug delivery applications. Science 2003; 299: 2045–2047.10.1126/science.1081298Search in Google Scholar

Li WJ, Nicol F, Szoka FC. GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery. Adv Drug Deliv Rev 2004; 56: 967–985.10.1016/j.addr.2003.10.041Search in Google Scholar

Liedtke C, Mazouni C, Hess KR, André F, Tordai A, Mejia JA, Symmans WF, Gonzalez-Angulo AM, Hennessy B, Green M, Cristofanilli M, Hortobagyi GN, Pusztai L. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol 2008; 26: 1275–1281.10.1200/JCO.2007.14.4147Search in Google Scholar

Liu DF, Makila E, Zhang HB, Herranz B, Kaasalainen M, Kinnari P, Salonen J, Hirvonen J, Santos HA. Nanostructured porous silicon-solid lipid nanocomposite: towards enhanced cytocompatibility and stability, reduced cellular association, and prolonged drug release. Adv Funct Mater 2013; 23: 1893–1902.10.1002/adfm.201202491Search in Google Scholar

Loo C, Lin A, Hirsch L, Lee MH, Barton J, Halas NJ, West J, Drezek R. Nanoshell-enabled photonics-based imaging and therapy of cancer. Technol Cancer Res Treat 2004; 3: 33–40.10.1177/153303460400300104Search in Google Scholar

Low SP, Voelcker NH, Canham LT, Williams KA. The biocompatibility of porous silicon in tissues of the eye. Biomaterials 2009; 30: 2873–2880.10.1016/j.biomaterials.2009.02.008Search in Google Scholar

MacDonald IJ, Dougherty TJ. Basic principles of photodynamic therapy. J Porphyr Phthalocyanines 2001; 5: 105–129.10.1002/jpp.328Search in Google Scholar

Maeda H, Sawa T, Konno T. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J Control Release 2001; 74: 47–61.10.1016/S0168-3659(01)00309-1Search in Google Scholar

Maeda H, Bharate GY, Daruwalla J. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur J Pharm Biopharm 2009; 71: 409–419.10.1016/j.ejpb.2008.11.010Search in Google Scholar PubMed

Malam Y, Loizidou M, Seifalian AM. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci 2009; 30: 592–599.10.1016/j.tips.2009.08.004Search in Google Scholar PubMed

Mann AP, Bhavane RC, Somasunderam A, Montalvo-Ortiz BL, Ghaghada KB, Volk D, Nieves-Alicea R, Suh KS, Ferrari M, Annapragada A, Gorenstein DG, Tanaka T. Thioaptamer conjugated liposomes for tumor vasculature targeting. Oncotarget 2011; 2: 298–304.10.18632/oncotarget.261Search in Google Scholar PubMed PubMed Central

Martinez JO, Boada C, Yazdi IK, Evangelopoulos M, Brown BS, Liu XW, Ferrari M, Tasciotti E. Short and long term, in vitro and in vivo correlations of cellular and tissue responses to mesoporous silicon nanovectors. Small 2013a; 9: 1722–1733.10.1002/smll.201201939Search in Google Scholar PubMed PubMed Central

Martinez JO, Chiappini C, Ziemys A, Faust AM, Kojic M, Liu XW, Ferrari M, Tasciotti E. Engineering multi-stage nanovectors for controlled degradation and tunable release kinetics. Biomaterials 2013b; 34: 8469–8477.10.1016/j.biomaterials.2013.07.049Search in Google Scholar PubMed PubMed Central

Massad-Ivanir N, Shtenberg G, Segal E. Advancing nanostructured porous Si-based optical transducers for label free bacteria detection. Adv Exp Med Biol 2012; 733: 37–45.10.1007/978-94-007-2555-3_4Search in Google Scholar PubMed

Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy – mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS. Cancer Res 1986; 46: 6387–6392.Search in Google Scholar

Mertz W. The essential trace-elements. Science 1981; 213: 1332–1338.10.1126/science.7022654Search in Google Scholar PubMed

Mintzer MA, Simanek EE. Nonviral vectors for gene delivery. Chem Rev 2009; 109: 259–302.10.1021/cr800409eSearch in Google Scholar PubMed

Moghimi SM, Hunter AC, Murray JC. Nanomedicine: current status and future prospects. FASEB J 2005; 19: 311–330.10.1096/fj.04-2747revSearch in Google Scholar PubMed

Nieto A, Hou HY, Sailor MJ, Freeman WR, Cheng LY. Ocular silicon distribution and clearance following intravitreal injection of porous silicon microparticles. Exp Eye Res 2013; 116: 161–168.10.1016/j.exer.2013.09.001Search in Google Scholar PubMed PubMed Central

Park JH, Lee S, Kim JH, Park K, Kim K, Kwon IC. Polymeric nanomedicine for cancer therapy. Prog Polym Sci 2008; 33: 113–137.10.1016/j.progpolymsci.2007.09.003Search in Google Scholar

Park JH, Gu L, von Maltzahn G, Ruoslahti E, Bhatia SN, Sailor MJ. Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat Mater 2009; 8: 331–336.10.1038/nmat2398Search in Google Scholar

Park JS, Kinsella JM, Jandial DD, Howell SB, Sailor MJ. Cisplatin-loaded porous Si microparticles capped by electroless deposition of platinum. Small 2011; 7: 2061–2069.10.1002/smll.201100438Search in Google Scholar

Parodi A, Quattrocchi N, van de Ven AL, Chiappini C, Evangelopoulos M, Martinez JO, Brown BS, Khaled SZ, Yazdi IK, Vittoria Enzo M, Isenhart L, Ferrari M, Tasciotti E. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nat Nanotechnol 2013; 8: 61–68.10.1038/nnano.2012.212Search in Google Scholar

Perelman LA, Pacholski C, Li YY, VanNieuwenhze MS, Sailor MJ. pH-triggered release of vancomycin from protein-capped porous silicon films. Nanomedicine 2008; 3: 31–43.10.2217/17435889.3.1.31Search in Google Scholar

Pitsillides CM, Joe EK, Wei XB, Anderson RR, Lin CP. Selective cell targeting with light-absorbing microparticles and nanoparticles. Biophys J 2003; 84: 4023–4032.10.1016/S0006-3495(03)75128-5Search in Google Scholar

Rajendran L, Knolker HJ, Simons K. Subcellular targeting strategies for drug design and delivery. Nat Rev Drug Discov 2010; 9: 29–42.10.1038/nrd2897Search in Google Scholar PubMed

Russo L, Colangelo F, Cioffi R, Rea I, De Stefano L. A mechanochemical approach to porous silicon nanoparticles fabrication. Materials 2011; 4: 1023–1033.10.3390/ma4061023Search in Google Scholar PubMed PubMed Central

Salonen J, Lehto VP. Fabrication and chemical surface modification of mesoporous silicon for biomedical applications. Chem Eng J 2008; 137: 162–172.10.1016/j.cej.2007.09.001Search in Google Scholar

Salonen J, Kaukonen AM, Hirvonen J, Lehto VP. Mesoporous silicon in drug delivery applications. J Pharm Sci 2008; 97: 632–653.10.1002/jps.20999Search in Google Scholar PubMed

Santos HA, editor. Porous silicon for biomedical applications. Cambridge UK, MA USA and Kidlington UK: Woodhead Publishing, 2014.Search in Google Scholar

Sarparanta M, Bimbo LM, Rytkonen J, Makila E, Laaksonen TJ, Laaksonen P, Nyman M, Salonen J, Linder MB, Hirvonen J, Santos HA, Airaksinen AJ. Intravenous delivery of hydrophobin-functionalized porous silicon nanoparticles: stability, plasma protein adsorption and biodistribution. Mol Pharmaceutics 2012a; 9: 654–663.10.1021/mp200611dSearch in Google Scholar PubMed

Sarparanta MP, Bimbo LM, Makila EM, Salonen JJ, Laaksonen PH, Helariutta AMK, Linder MB, Hirvonen JT, Laaksonen TJ, Santos HA, Airaksinen AJ. The mucoadhesive and gastroretentive properties of hydrophobin-coated porous silicon nanoparticle oral drug delivery systems. Biomaterials 2012b; 33: 3353–3362.10.1016/j.biomaterials.2012.01.029Search in Google Scholar PubMed

Schott AF, Hayes DF. Defining the benefits of neoadjuvant chemotherapy for breast cancer. J Clin Oncol 2012; 30: 1747–1749.10.1200/JCO.2011.41.3161Search in Google Scholar PubMed

Secret E, Maynadier M, Gallud A, Gary-Bobo M, Chaix A, Belamie E, Maillard P, Sailor MJ, Garcia M, Durand J-O, Cunin F. Anionic porphyrin-grafted porous silicon nanoparticles for photodynamic therapy. Chem Commun 2013a; 49: 4202–4204.10.1039/c3cc38837aSearch in Google Scholar PubMed

Secret E, Smith K, Dubljevic V, Moore E, Macardle P, Delalat B, Rogers ML, Johns TG, Durand JO, Cunin F, Voelcker NH. Antibody-functionalized porous silicon nanoparticles for vectorization of hydrophobic drugs. Adv Healthc Mater 2013b; 2: 718–727.10.1002/adhm.201200335Search in Google Scholar PubMed

Secret E, Maynadier M, Gallud A, Chaix A, Bouffard E, Gary-Bobo M, Marcotte N, Mongin O, El Cheikh K, Hugues V, Auffan M, Frochot C, Morère A, Maillard P, Blanchard-Desce M, Sailor MJ, Garcia M, Durand J-O, Cunin F. Two-photon excitation of porphyrin-functionalized porous silicon nanoparticles for photodynamic therapy. Adv Mater 2014; 26: 7643–7648.10.1002/adma.201403415Search in Google Scholar PubMed

Segal E, Perelman LA, Cunin F, Di Renzo F, Devoisselle JM, Li YY, Sailor MJ. Confinement of thermoresponsive hydrogels in nanostructured porous silicon dioxide templates. Adv Funct Mater 2007; 17: 1153–1162.10.1002/adfm.200601077Search in Google Scholar

Serda RE, Mack A, Pulikkathara M, Zaske AM, Chiappini C, Fakhoury JR, Webb D, Godin B, Conyers JL, Liu XW, Bankson JA, Ferrari M. Cellular association and assembly of a multistage delivery system. Small 2010a; 6: 1329–1340.10.1002/smll.201000126Search in Google Scholar PubMed PubMed Central

Serda RE, Mack A, van de Ven AL, Ferrati S, Dunner K, Jr., Godin B, Chiappini C, Landry M, Brousseau L, Liu X, Bean AJ, Ferrari M. Logic-embedded vectors for intracellular partitioning, endosomal escape, and exocytosis of nanoparticles. Small 2010b; 6: 2691–2700.10.1002/smll.201000727Search in Google Scholar PubMed PubMed Central

Shahbazi MA, Hamidi M, Makila EM, Zhang HB, Almeida PV, Kaasalainen M, Salonen JJ, Hirvonen JT, Santos HA. The mechanisms of surface chemistry effects of mesoporous silicon nanoparticles on immunotoxicity and biocompatibility. Biomaterials 2013; 34: 7776–7789.10.1016/j.biomaterials.2013.06.052Search in Google Scholar PubMed

Shen HF, You J, Zhang GD, Ziemys A, Li QP, Bai LT, Deng XY, Erm DR, Liu XW, Li C, Ferrari M. Cooperative, nanoparticle-enabled thermal therapy of breast cancer. Adv Healthc Mater 2012; 1: 84–89.10.1002/adhm.201100005Search in Google Scholar PubMed PubMed Central

Shen HF, Rodriguez-Aguayo C, Xu R, Gonzalez-Villasana V, Mai JH, Huang Y, Zhang GD, Guo XJ, Bai LT, Qin GT, Deng XY, Li QP, Erm DR, Aslan B, Liu XW, Sakamoto J, Chavez-Reyes A, Han HD, Sood AK, Ferrari M, Lopez-Berestein G. Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery. Clin Cancer Res 2013a; 19: 1806–1815.10.1158/1078-0432.CCR-12-2764Search in Google Scholar PubMed PubMed Central

Shen JL, Xu R, Mai JH, Kim HC, Guo XJ, Qin GT, Yang Y, Wolfram J, Mu CF, Xia XJ, Gu JH, Liu XW, Mao ZW, Ferrari M, Shen HF. High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics. ACS Nano 2013b; 7: 9867–9880.10.1021/nn4035316Search in Google Scholar PubMed PubMed Central

Shen JL, Kim HC, Su H, Wang F, Wolfram J, Kirui D, Mai JH, Mu CF, Ji LN, Mao ZW, Shen HF. Cyclodextrin and polyethylenimine functionalized mesoporous silica nanoparticles for delivery of siRNA cancer therapeutics. Theranostics 2014; 4: 487–497.10.7150/thno.8263Search in Google Scholar PubMed PubMed Central

Shubayev VI, Pisanic TR, Jin SH. Magnetic nanoparticles for theragnostics. Adv Drug Deliv Rev 2009; 61: 467–477.10.1016/j.addr.2009.03.007Search in Google Scholar PubMed PubMed Central

Sun W, Puzas JE, Sheu TJ, Fauchet PM. Porous silicon as a cell interface for bone tissue engineering. Phys Status Solidi A 2007a; 204: 1429–1433.10.1002/pssa.200674377Search in Google Scholar

Sun W, Puzas JE, Sheu TJ, Liu X, Fauchet PM. Nano- to microscale porous silicon as a cell interface for bone-tissue engineering. Adv Mater 2007b; 19: 921.10.1002/adma.200600319Search in Google Scholar

Tamarov KP, Osminkina LA, Zinovyev SV, Maximova KA, Kargina JV, Gongalsky MB, Ryabchikov Y, Al-Kattan A, Sviridov AP, Sentis M, Ivanov AV, Nikiforov VN, Kabashin AV, Timoshenko VY. Radio frequency radiation-induced hyperthermia using si nanoparticle-based sensitizers for mild cancer therapy. Sci Rep 2014; 4: 7034.10.1038/srep07034Search in Google Scholar PubMed PubMed Central

Tanaka T, Mangala LS, Vivas-Mejia PE, Nieves-Alicea R, Mann AP, Mora E, Han HD, Shahzad MMK, Liu XW, Bhavane R, Gu JH, Fakhoury JR, Chiappini C, Lu CH, Matsuo K, Godin B, Stone RL, Nick AM, Lopez-Berestein G, Sood AK, Ferrari M. Sustained small interfering RNA delivery by mesoporous silicon particles. Cancer Res 2010; 70: 3687–3696.10.1158/0008-5472.CAN-09-3931Search in Google Scholar PubMed PubMed Central

Tasciotti E, Liu XW, Bhavane R, Plant K, Leonard AD, Price BK, Cheng MMC, Decuzzi P, Tour JM, Robertson F, Ferrari M. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat Nanotechnol 2008; 3: 151–157.10.1038/nnano.2008.34Search in Google Scholar PubMed

Tatum JL, Kelloff GJ, Gillies RJ, Arbeit JM, Brown JM, Chao KSC, Chapman JD, Eckelman WC, Fyles AW, Giaccia AJ, Hill RP, Koch CJ, Krishna MC, Krohn KA, Lewis JS, Mason RP, Melillo G, Padhani AR, Powis G, Rajendran JG, Reba R, Robinson SP, Semenza GL, Swartz HM, Vaupel P, Yang D, Croft B, Hoffman J, Liu GY, Stone H, Sullivan D. Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int J Radiat Biol 2006; 82: 699–757.10.1080/09553000601002324Search in Google Scholar PubMed

Tolli MA, Ferreira MPA, Kinnunen SM, Rysa J, Makila EM, Szabo Z, Serpi RE, Ohukainen PJ, Valimaki MJ, Correia AMR, Salonen JJ, Hirvonen JT, Ruskoaho HJ, Santos HA. In vivo biocompatibility of porous silicon biomaterials for drug delivery to the heart. Biomaterials 2014; 35: 8394–8405.10.1016/j.biomaterials.2014.05.078Search in Google Scholar

Torchilin VP. Drug targeting. Eur J Pharm Sci 2000; 11: S81–S91.10.1016/S0928-0987(00)00166-4Search in Google Scholar

Tzur-Balter A, Gilert A, Massad-Ivanir N, Segal E. Engineering porous silicon nanostructures as tunable carriers for mitoxantrone dihydrochloride. Acta Biomater 2013; 9: 6208–6217.10.1016/j.actbio.2012.12.010Search in Google Scholar PubMed

Tzur-Balter A, Shatsberg Z, Beckerman M, Segal E, Artzi N. Mechanism of erosion of nanostructured porous silicon drug carriers in neoplastic tissues. Nat Commun 2015; 6: 6208.10.1038/ncomms7208Search in Google Scholar PubMed PubMed Central

Van de Ven AL, Kim P, Haley OH, Fakhoury JR, Adriani G, Schmulen J, Moloney P, Hussain F, Ferrari M, Liu X, Yun S-H, Decuzzi P. Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution. J Control Release 2012; 158: 148–155.10.1016/j.jconrel.2011.10.021Search in Google Scholar PubMed PubMed Central

Vaupel P, Kallinowski F, Okunieff P. Blood-flow, oxygen and nutrient supply, and metabolic microenvironment of human-tumors – a review. Cancer Res 1989; 49: 6449–6465.Search in Google Scholar

Veiseh O, Kievit FM, Mok H, Ayesh J, Clark C, Fang C, Leung M, Arami H, Park JO, Zhang MQ. Cell transcytosing poly-arginine coated magnetic nanovector for safe and effective siRNA delivery. Biomaterials 2011; 32: 5717–5725.10.1016/j.biomaterials.2011.04.039Search in Google Scholar PubMed PubMed Central

Wang AZ, Langer R, Farokhzad OC. Nanoparticle delivery of cancer drugs. Annu Rev Med 2012; 63: 185–198.10.1146/annurev-med-040210-162544Search in Google Scholar PubMed

Wu EC, Andrew JS, Cheng LY, Freeman WR, Pearson L, Sailor MJ. Real-time monitoring of sustained drug release using the optical properties of porous silicon photonic crystal particles. Biomaterials 2011; 32: 1957–1966.10.1016/j.biomaterials.2010.11.013Search in Google Scholar PubMed PubMed Central

Xiao L, Gu L, Howell SB, Sailor MJ. Porous silicon nanoparticle photosensitizers for singlet oxygen and their phototoxicity against cancer cells. ACS Nano 2011; 5: 3651–3659.10.1021/nn1035262Search in Google Scholar PubMed PubMed Central

Xu R, Huang Y, Mai JH, Zhang GD, Guo XJ, Xia XJ, Koay EJ, Qin GT, Erm DR, Li QP, Liu XW, Ferrari M, Shen HF. Multistage vectored siRNA targeting ataxia-telangiectasia mutated for breast cancer therapy. Small 2013; 9: 1799–1808.10.1002/smll.201201510Search in Google Scholar PubMed PubMed Central

Yokoi K, Godin B, Oborn CJ, Alexander JF, Liu XW, Fidler IJ, Ferrari M. Porous silicon nanocarriers for dual targeting tumor associated endothelial cells and macrophages in stroma of orthotopic human pancreatic cancers. Cancer Lett 2013; 334: 319–327.10.1016/j.canlet.2012.09.001Search in Google Scholar PubMed PubMed Central

Zhang MZ, Xu R, Xia XJ, Yang Y, Gu JH, Qin GT, Liu XW, Ferrari M, Shen HF. Polycation-functionalized nanoporous silicon particles for gene silencing on breast cancer cells. Biomaterials 2014; 35: 423–431.10.1016/j.biomaterials.2013.09.033Search in Google Scholar PubMed PubMed Central

Received: 2015-1-4
Accepted: 2015-2-26
Published Online: 2015-4-14
Published in Print: 2015-6-1

©2015 by De Gruyter

Downloaded on 28.3.2024 from https://www.degruyter.com/document/doi/10.1515/revce-2015-0001/html
Scroll to top button